For adults with Fabry disease
Picture what
long-lasting
treatment
can do*
Elfabrio is an enzyme replacement therapy (ERT) that has been shown to work safely and effectively over the long term in adults with Fabry disease.† And with a long half-life, Elfabrio can last for a long time in your body.
| * | Elfabrio has an initial half-life of 78.9 ± 10.3 hours. Clinical studies have not shown that a long half-life results in a medicine working better or more safely. Infusions are every 2 weeks. |
| † | Trials within the Full Prescribing Information extend up to 2 years. |
| ‡ | The initial 4-6 infusions are no less than 3-4 hours. Maintenance infusions are as short as 1.5 hours. |
Designed with your needs in mind
One-stop
patient support
Managing Fabry can be challenging
Fabry is a progressive disease, which means it usually gets worse over time. Early diagnosis and treatment can increase your chances of managing Fabry symptoms and slowing down disease progression.
 |
New to ERT? Many people with Fabry disease put off treatment until symptoms become serious, at which time organ damage may have already begun. |
 |
Switching treatment? It's important to find a treatment you can stay on when living with a progressive disease like Fabry. |
